You are viewing the site in preview mode

Skip to content


  • Poster presentation
  • Open Access

Efficient isolation of monocytes from PBMCs utilizing a newly developed material

  • 1,
  • 1 and
  • 2
Journal for ImmunoTherapy of Cancer20153 (Suppl 2) :P212

  • Published:


  • Dendritic Cell
  • Cancer Treatment
  • Cost Performance
  • Magnetic Bead
  • Operating Process


Recent years immunotherapy has been used to treat various diseases especially cancer. The dendritic cell therapy has been one of the most widely practiced therapies in clinics and usually monocytes are isolated as the source of dendritic cells. However, although dendritic cell therapy shows its effect in cancer treatment, a big problem is one cannot guarantee an enough number of cells for treatment. This is mainly due to the inefficiency of monocyte isolation.


Up to now, various methods for selectively isolating monocytes have been developed to trap as many monocytes as possible. For example, a method using a density-gradient centrifugation and a method using magnetic beads with antibodies affinitive to cells have been promoted for several years. However, these methods show rare possibilities to instead the plastic adherence which is the most commonly used method for monocyte isolation. The first reason is proposed to be the complicated operating process. The second reason might be their low cost performance.


Here we present a new material that gives a high affinity to monocytes but other PBMCs. Plastic dishes or glass dishes coated with this material were used to attract monocytes using a protocol exactly the same with the traditional plastic adherence protocol. The differentiation of monocytes to dendritic cells were carried out by adding GM-CSF and IL-4 to the culture medium and the maturation of those dendritic cells was proceeded by addition of TNF alpha and PGE2.


As the results indicated, we gained more adhered monocytes comparing with the traditional plastic adherence. Therefore, we believe that this material will be widely used in monocyte isolation and hence contribute to dendritic cell therapy.

Authors’ Affiliations

Medical Device Development Laboratories, Kaneka Corp., Takasago, Japan
University of Kyushu, Japan, Fukuoka, Japan


© Zhang et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.